What is the difference between Mod-GRF(1-29) and Sermorelin?

Mod-GRF(1-29): Mod-GRF(1-29) is a stabilized analog of growth hormone-releasing hormone (GHRH) that spans residues 1–29 of the native peptide. Unlike CJC-1295 (which includes a Drug Affinity Complex for multi-day half-life), Mod-GRF(1-29) has a short ~30-minute active window — mimicking the natural GHRH pulse pattern. It is the preferred GHRH component for precise, pulsatile GH protocols when combined with a GHRP. Sermorelin: Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take Mod-GRF(1-29) and Sermorelin together?

There is no specific, well-documented interaction rule for combining Mod-GRF(1-29) and Sermorelin in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, Mod-GRF(1-29) or Sermorelin?

Mod-GRF(1-29) is currently research-stage and Sermorelin is fda-approved. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

Mod-GRF(1-29) vs Sermorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

Mod-GRF(1-29)

Research-stage

Mod-GRF(1-29) is a stabilized analog of growth hormone-releasing hormone (GHRH) that spans residues 1–29 of the native peptide. Unlike CJC-1295 (which includes a Drug Affinity Complex for multi-day half-life), Mod-GRF(1-29) has a short ~30-minute active window — mimicking the natural GHRH pulse pattern. It is the preferred GHRH component for precise, pulsatile GH protocols when combined with a GHRP.

Full profile

Sermorelin

FDA-approved

Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.

Full profile

	Mod-GRF(1-29)	Sermorelin
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	Modified GRF(1-29), CJC-1295 without DAC, Tetrasubstituted GRF, Sermorelin analog	GHRH 1-29, GRF 1-29 NH2, Geref
Evidence	Research-stage	FDA-approved
Dosing range	100mcg–200mcg mcg, 2–3x daily, co-administered with a GHRP (pre-sleep, pre-workout, and/or upon waking)	100mcg–500mcg mcg, once daily (before sleep)
Administration	Subcutaneous injection, Intramuscular injection	Subcutaneous injection
Key side effects	Water retention (mild, dose-dependent), Tingling / numbness in extremities (carpal tunnel-like at high doses), Increased appetite (via GHRP component — less with Mod-GRF alone), Flushing or warmth at injection site	Injection site redness, Headache, Flushing, Dizziness
Cited sources	2 references	1 reference

Key differences

Evidence level differs: Mod-GRF(1-29) is research-stage, while Sermorelin is fda-approved.
Administration: Mod-GRF(1-29) — Subcutaneous injection, Intramuscular injection; Sermorelin — Subcutaneous injection.
Frequency: Mod-GRF(1-29) is typically 2–3x daily, co-administered with a GHRP (pre-sleep, pre-workout, and/or upon waking); Sermorelin is once daily (before sleep).
Research depth: this profile cites 2 sources for Mod-GRF(1-29) vs 1 for Sermorelin.

How each works

Mod-GRF(1-29)

Native GHRH(1-29) is rapidly cleaved by plasma dipeptidyl peptidase IV (DPP-IV) within 2–3 minutes. Mod-GRF(1-29) incorporates four amino acid substitutions (positions 2, 8, 15, 27) that resist DPP-IV degradation, extending the half-life to approximately 30 minutes while preserving GHRH receptor binding affinity. This creates a half-life window aligned with physiological GH pulsatility, making it suitable for 2–3x daily injections that mimic natural GH release patterns.

Sermorelin

Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.

Read the full Mod-GRF(1-29) profile Read the full Sermorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.